US 10273288
Neutralizing antibodies to Ebola virus glycoprotein and their use
granted A61KA61K2039/505
Quick answer
US patent 10273288 (Neutralizing antibodies to Ebola virus glycoprotein and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K2039/505